// App-Quantinova.ai

: Identification of five novel osteoarthritis susceptibility loci through the UK biobank resourse of five novel osteoarthritis susceptibility loci through the UK biobank resourse

Researchers

Presenter

  • E. Zengini

Principal Investigators

  • K. Hatzikotoulas

  • I. Tachmazidou

  • S. Hackinger

  • U. Styrkarsdottir

  • D. Suveges

  • B. Killian

  • A. Gilly

  • T. Ingvarsson

  • H. Jonsson

  • G. Babis

  • U. Thorsteinsdottir

  • K. Stefansson

  • J.M. Wilkinson

  • E. Zeggini

Medical Centers

  • University of Sheffield, Sheffield, United Kingdom

  • Dromokaiteio Psychiatric Hosp. of Athens, Athens, Greece

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • deCODE Genetics, Reykjavik, Iceland

  • Akureyri Hosp, Akureyri, Iceland

  • University of Iceland, Reykjavik, Iceland

  • The Natl. Univ. Hosp. of Iceland, Reykjavik, Iceland

  • University of Athens, Athens, Greece

Locations

  • United Kingdom

  • Greece

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Transcription factor Maf

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved